Cyprotex PLC (LSE:CRX) - Share price - Overview

Stock Report

Cyprotex PLC CRX

Last Price
£-

Day Change
-|-%

As of -
- | GBP
Minimum 15 Minutes Delay.

Last Close-
Day Range-
Mkt Cap36.13Mil
52-Wk Range-
Yield %-
ISINGB00BP25RZ14
Volume-
P/E-
P/S-
P/CF-

Share Price

Financials
201320142015
More ...
Income Statement
Revenue9.7711.5715.61
Operating Income0.61-3.751.98
Net Income-0.80-4.17-6.51
Basic EPS-0.04-0.19-0.29
Avg. Diluted Shares Outstanding222222
Balance Sheet
Current Assets9.767.4210.12
Non Current Assets7.745.635.35
Total Assets17.5113.0415.47
Current Liabilities2.011.411.83
Total Liabilities11.1910.5919.24
Total Equity6.312.45-3.78
Cash Flow
Operating Cash Flow1.53-1.323.55
Capital Expenditure-1.17-1.68-0.83
Free Cash Flow0.36-3.002.72

In millions, except "Basic EPS". Currency is GBP.

Company Profile

Cyprotex PLC together with its subsidiaries provides in vitro and in silico ADMET and PK (absorption, distribution, metabolism, excretion, toxicity, and pharmacokinetics) information to the pharmaceutical and biotechnology industry.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

144
Key Stats
More ...
Price/Earning TTM-
Price/Book-
Price/Sales TTM-
Rev Growth (3 year avg)23.30
EPS Growth (3 year avg)-
Operating Margin % TTM12.66
Net Margin % TTM-41.69
ROE TTM-
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.